Michael Moreno
Long/short equity, growth, portfolio strategy, biotech

Fibrocell Science Steadies Itself For Growth After Listing On NYSE

Fibrocell Science (NASDAQ:FCSC) is an autologous cell therapy company involved in the development of medicines for aesthetic, medical and scientific application. FCSC's diverse drug pipeline revolves around applications of the fibroblast cell. The fibroblast cell plays an important role in the production of growth factors and collagen that support the skin and soft tissues. The fibroblast cell is the most important cell in regards to synthesizing the extracellular matrix and collagen within the skin itself. Here is a diagram showing how the organelles and fibroblast cells work together.

The fibroblast cell is the most common connective tissue in mammals and reptiles. Collagen is a protein that gives skin its durability and elasticity and plays a major role in...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details